One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category of blood-based cancer testing.
Guardant’s Shield colon cancer blood test snags UnitedHealth coverage
One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category of blood-based cancer testing.